Related Experiment Video
Updated: Jul 27, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Involvement of p21ras in activation of extracellular signal-regulated kinase 2
A M de Vries-Smits1, B M Burgering, S J Leevers
1Laboratory for Physiological Chemistry, University of Utrecht, The Netherlands.
Abstract:
Many growth factors upon stimulation of their receptors induce the activity of extracellular signal-regulated kinases, ERKs, also known as MAP kinases. Several of these growth factors also activate the ras proto-oncogene product, p21ras (Ras), by stimulating the conversion of the inactive GDP-bound form of Ras to the active GTP-bound form. We have shown that direct introduction of p21ras oncoprotein into cells in the absence of growth factors activates ERKs within five minutes, which indicates that normal p21ras may be involved in the activation of ERKs by growth factors. Here we use a recombinant vaccinia virus expressing an interfering mutant of p21ras, RasAsn17, to investigate this question. In NIH3T3 cells that overexpress the insulin receptor, this recombinant virus inhibits insulin-induced activation of ERK2 completely, but there is no inhibition of insulin-induced activation of phosphatidylinositol-3-kinase. In rat-1 cells the recombinant virus inhibited ERK2 activity induced by platelet-derived growth factor (PDGF) but not by phorbol ester. We conclude that p21ras mediates insulin- and PDGF-induced activation of ERK2.
Insights
Ras proto-oncogene product (Ras) activation of extracellular signal-regulated kinases (ERKs) is crucial for growth factor signaling. Ras mediates insulin and platelet-derived growth factor (PDGF)-induced ERK activation.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Oncogene research
Background:
- Growth factors activate extracellular signal-regulated kinases (ERKs), also known as MAP kinases.
- Growth factors also activate p21ras (Ras) by promoting its conversion from GDP-bound to GTP-bound form.
- Direct introduction of p21ras oncoprotein activates ERKs rapidly, suggesting its role in growth factor signaling.
Purpose of the Study:
- To investigate the role of p21ras in mediating growth factor-induced ERK activation.
- To determine if Ras is a common mediator for different growth factor signaling pathways.
Main Methods:
- Utilized a recombinant vaccinia virus expressing an interfering mutant of p21ras (RasAsn17).
- Assessed the effect of RasAsn17 on insulin-induced ERK2 and phosphatidylinositol-3-kinase activation in NIH3T3 cells.
- Examined the impact of RasAsn17 on ERK2 activity induced by platelet-derived growth factor (PDGF) and phorbol ester in rat-1 cells.
Main Results:
- RasAsn17 completely inhibited insulin-induced ERK2 activation in NIH3T3 cells overexpressing the insulin receptor.
- RasAsn17 did not inhibit insulin-induced phosphatidylinositol-3-kinase activation.
- RasAsn17 inhibited PDGF-induced ERK2 activity in rat-1 cells but not phorbol ester-induced ERK2 activity.
Conclusions:
- p21ras (Ras) is a critical mediator in the signaling pathways for insulin and PDGF.
- Ras specifically mediates the activation of ERK2 by these growth factors.
- The findings highlight Ras's central role in linking specific growth factor receptors to ERK activation.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

